Lupus discovery lends clues to the fight against long COVID
PharmaVoice
JULY 27, 2022
So far, pharma has yet to provide an answer for long COVID. But award-winning lupus research by Yale professor Akiko Iwasaki help lead the way.
Wed.Jul 27, 2022
299 
6 Major Trends Boosting the Telemedicine Market in Health Care
Pharmacy Times
JULY 27, 2022
The number of medical visits carried out via telehealth grew from 840,000 in 2019 to 52.7 million in 2020.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Woman of the Week: Applied BioMath's Katie Williams
PharmaVoice
JULY 27, 2022
The 2022 president of Women in Bio is equal parts math and gender parity evangelist.
Summertime Medication Sun Safety Tips
Pharmacy Times
JULY 27, 2022
With the vast number of drugs that can induce photosensitivity, patients taking any of these medications should receive safety counseling, especially during the summer months.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
What’s next for Biogen? Here’s what executives are saying
PharmaVoice
JULY 27, 2022
A trickling launch for Aduhelm and a middling earnings report give Biogen executives a lot to talk about. Is there hope?
Additional COVID-19 Booster Dose Strengthens Waning Immunity Against Omicron Subvariants
Pharmacy Times
JULY 27, 2022
Study findings coincide with the US government considering recommendations of a second COVID-19 booster dose for adults under 50 years of age.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
How Pharmacists Can Have Their Voices Heard in Public Policy
Pharmacy Times
JULY 27, 2022
We have to have this one voice that we've been talking about, this one consistent message.
FDA grants priority review for Biogen’s tofersen to treat ALS
Pharmaceutical Technology
JULY 27, 2022
The US Food and Drug Administration (FDA) has granted priority review for Biogen ’s New Drug Application (NDA) for investigational drug, tofersen, to treat superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS). A decision from the regulatory agency on approval for the drug is anticipated on 25 January next year. The FDA also plans to hold an advisory committee meeting for the NDA.
Pharmacist-Based Deprescribing Reduced Prescription, Cumulative Use of High-Risk Drugs in Older Adults
Pharmacy Times
JULY 27, 2022
Two pharmacist-based deprescribing models reduced the use and prescription of anticholinergics, a high-risk drug in older adults, providing evidence for the use of pharmacists is practitioners of deprescribing.
Healthware forms new medical communications division
pharmaphorum
JULY 27, 2022
Health innovation and technology specialist Healthware Group has added another element to its business with the launch of a dedicated medical communications and education division. The new unit – dubbed Healthware MedComms – promises to take a fresh approach to medical communications that meets “the always-on, audience-centric, evidence-driven demands of today’s modern clinical environment.” It adds to Healthware’s fast-growing presence in the healthcare communications se
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
FDA Accepts sBLA of Trastuzumab Deruxtecan for Treatment of Individuals With HER2-Low Breast Cancer
Pharmacy Times
JULY 27, 2022
Trastuzumab deruxtecan is an engineered HER2-directed antibody drug conjugate being jointly developed and commercialized by AstraZeneca and Daiichi Sankyo.
Global comparator data signal “alarm bells” for UK Government, says APBI
pharmaphorum
JULY 27, 2022
Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Despite the UK’s potential as an international life sciences leader, it lags many competitors in a number of key metrics, including access to new medicines and global share of clinical trial recruitment. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alar
Newly Identified Clinical Symptoms of Monkeypox Similar to Common STI Symptoms
Pharmacy Times
JULY 27, 2022
Researchers suggest that the current case definition of monkeypox be broadened to include genital lesions and sores on the mouth or anus as symptoms to prevent misdiagnoses.
Teva closes on $4.25bn deal to settle US-wide opioid litigation
pharmaphorum
JULY 27, 2022
Teva Pharmaceutical says it has reached an agreement in principle to settle thousands of lawsuits accusing it of fuelling the opioid crisis in the US for up to $4.25 billion, including already settled cases. The Israel-headquartered company – one of the largest suppliers of opioids in the US – said the tentative agreement is with states, Native American tribes and local plaintiffs and will involve payments over 13 years.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
COVID-19 Infection in Children Associated with Post-COVID Conditions, Including Fatigue, Weakness
Pharmacy Times
JULY 27, 2022
SARS-CoV-2 infection was associated with post-COVID-19 conditions for children, with associated risk factors including length of hospitalization, number of acute symptoms, and older age.
Accelerating Market Access with Data-Driven Payer Engagement
PharmExec
JULY 27, 2022
Using data visualizations to improve access to payers.
FDA to Review Supplemental Biologics License Application for Another Adalimumab Biosimilar
Pharmacy Times
JULY 27, 2022
FDA accepts supplemental Biologics License Application for Hyrimoz HCF, a biosimilar with the same indications as adalimumab (Humira).
Has Data Science Caught up with Science Data: Q&A with Mike McKee, President of Dotmatics
PharmExec
JULY 27, 2022
Has data science finally reached a level playing field with all of the science data being uncovered in the make, test, decide innovation cycle?
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Examples of Advocacy in the Community for Public Policy Issues
Pharmacy Times
JULY 27, 2022
You just need to tell your story and be genuine and be real, and it makes such a difference.
AmerisourceBergen aims to make digital therapeutics access easier
pharmaphorum
JULY 27, 2022
Pharma distributor AmerisourceBergen is working on a platform to make access to digital therapeutics (DTx) easier in the US by providing a unified system for ordering, dispensing and fulfilment. The new system – called DTx Connect – aims to help physicians order both prescription and non-prescription DTx and diagnostics through a simple interface, and monitor shipping and delivery to their patients.
Oncology Overview: Pirtobrutinib—A New BTK Inhibitor
Pharmacy Times
JULY 27, 2022
Pirtobrutinib is under investigation in clinical trials in patients with CLL/small lymphocytic lymphoma, mantle cell lymphoma, and non-Hodgkin lymphoma.
Novavax Covid-19 vaccine gets Australian TGA approval for adolescents
Pharmaceutical Technology
JULY 27, 2022
Novavax has r eceived expanded approval for provisional registration from the Australian Therapeutic Goods Agency (TGA) for its Covid-19 vaccine, Nuvaxovid (NVX-CoV2373), for use in adolescents aged 12 to 17 years. Nuvaxovid is indicated for active immunisation for the prevention of Covid-19 in individuals of this age group. It is the first protein-based vaccine to be offered in Australia for adolescents aged 12 to 17 years.
Daily OTC Pearl: Simethicone
Pharmacy Times
JULY 27, 2022
Simethicone helps with relief of gas, pressure, and bloating.
Chiesi reinforces commitment to reducing emissions
Pharma Times
JULY 27, 2022
First carbon minimal pMDI is on track with the joint goal of benefitting patients and the planet
Daily Medication Pearl: Angiotensin II (Giapreza) Injection
Pharmacy Times
JULY 27, 2022
Angiotensin II (Giapreza) is a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock.
Low-Cost Ways To Get New Pharmacy Patients
DiversifyRx
JULY 27, 2022
Getting new pharmacy patients doesn’t have to be expensive. Patients are the lifeblood of pharmacies. Whether you focus on dispensing prescriptions, selling supplements, or fixing hormones, you need pharmacy patients. . I am a huge fan of guerilla-style marketing. Over the years, I have perfected many tactics that work well for independent pharmacies as we want our patients to come to us, IRL (in real life!).
Quviviq From Idorsia Pharmaceuticals
Pharmacy Times
JULY 27, 2022
The FDA has approved daridorexant (Quviviq; Idorsia Pharmaceuticals, US Inc) to treat adults with insomnia.
Using RWD to Unlock Better Outcomes for IBD and NASH Patients
PharmExec
JULY 27, 2022
Thu, Jul 28, 2022 11:00 AM EDT With no cure for IBD and other conditions, like NASH, treatments are aimed at reducing symptoms and preventing complications. Real-world data and AI applications provide a unique opportunity to better understand disease progression, treatment effectiveness, and outcomes.
Tip of the Week: Broaden Your View of Value Creation for Services
Pharmacy Times
JULY 27, 2022
It is important to step back and see value creation for services from a broader and more fundamental perspective than the individual, daily tasks in the pharmacy.
Q&A with Errik Anderson, Alloy Therapeutics Founder and CEO
PharmExec
JULY 27, 2022
Anderson speaks about his work with new technology and platforms.
PCI Pharma Services Expands UK Manufacturing Facility
Pharmaceutical Commerce
JULY 27, 2022
CDMO’s new project focuses on addressing needs in oncology sector.
Sanofi Partners With Howard University
PharmExec
JULY 27, 2022
Howard University College of Pharmacy will now offer a two-year post-professional Doctorate in Pharmacy fellowship program.
Robotics hiring levels in the pharmaceutical industry rose in June 2022
Pharmaceutical Technology
JULY 27, 2022
The proportion of pharmaceutical companies hiring for robotics related positions rose in June 2022 compared with the equivalent month last year, with 21.3% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 17.2% of companies who were hiring for robotics related jobs a year ago and an increase compared to the figure of 21.1% in May 2022.
Let's personalize your content